Monitoring Blood Pressure at Home

NCT ID: NCT06247111

Last Updated: 2025-09-22

Basic Information

• Recruitment Status: ACTIVE_NOT_RECRUITING
• Clinical Phase: NA
• Total Enrollment: 24 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2024-07-10
• Study Completion Date: 2026-06-30

Brief Summary

The overall goal of this project is to determine if measuring blood pressure at home and staying in contact with a team of pharmacists and physicians to manage your blood pressure is feasible. The study will enroll 24 participants at UAB who are seen at the Emergency Department Post-Discharge Clinic. Half of the participants (12 patients) will be asked to measure their blood pressure at home, and half of the participants (12 patients) will continue to receive usual care. Participants who measure their blood pressure at home will also meet with a pharmacist weekly over the phone to discuss blood pressure readings and have blood pressure medications prescribed if needed. This program will last 3 months.

Detailed Description

For all participants:

1. Participants will receive information on the importance of measuring blood pressure and ways to improve blood pressure.

2. Participants will complete questionnaires describing current socioeconomic position, medical history and healthcare needs.

3. Participants will come in for one research clinic visit to get blood pressure measured 3 months after enrollment in this study.

For participants asked to measure blood pressure at home:

1. Measure blood pressure twice a day at home, following the instructions provided. The study will provide participants with the device and send text message reminders each week day. Participants will return the device at study visit 3 months from now.

2. Following the instructions provided, participants will talk to a pharmacist over the phone weekly to discuss blood pressure and medications. All medication changes will be discussed with a collaborating physician.

3. Participants will complete questionnaires on satisfaction with the program.

Conditions

Hypertension

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Usual Care

Participants receive usual care from providers to manage their blood pressure

Group Type: PLACEBO_COMPARATOR

Usual care

Intervention Type: OTHER

Participants receive usual care, no intervention.

Remote Blood Pressure Monitoring + Telehealth

Participants will undergo remote blood pressure monitoring and pharmacist led telehealth intervention for blood pressure management

Group Type: ACTIVE_COMPARATOR

Remote Blood Pressure Monitoring + Telehealth

Intervention Type: OTHER

Remote blood pressure monitoring and pharmacist led telehealth intervention for blood pressure management

Interventions

Remote Blood Pressure Monitoring + Telehealth

Remote blood pressure monitoring and pharmacist led telehealth intervention for blood pressure management

Intervention Type: OTHER

Usual care

Participants receive usual care, no intervention.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Patients seen at the Emergency Department Post-Discharge Clinic
• >=18 years
• Blood pressure >=130/80 mmHg and <=160/100 mmHg
• English speakers
• Have a smartphone

Exclusion Criteria

• Patients with blood pressure >=160 mmHg

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

National Institute on Minority Health and Health Disparities (NIMHD)

NIH

Sponsor Role: collaborator

University of Alabama at Birmingham

OTHER

Sponsor Role: lead

Responsible Party

Lama Ghazi

Assistant Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Lama Ghazi, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Alabama at Birmingham

Locations

University of Alabama at Birmingham

Birmingham, Alabama, United States

Countries

United States

Other Identifiers

P50MD017338

Identifier Type: NIH

Identifier Source: secondary_id

View Link

IRB-300012428

Identifier Type: -

Identifier Source: org_study_id